Volume 95 Issue 45 | pp. 14-15 | Concentrates
Issue Date: November 13, 2017

GSK recruits R&D head from Calico

Department: Business
Keywords: Drug discovery, GlaxoSmithKline, GSK, Calico
[+]Enlarge
Barron
Credit: GSK
A photo of Hal Barron.
 
Barron
Credit: GSK

Patrick Vallance, Glaxo­Smith­Kline’s president of R&D, will leave the British drug giant in March 2018 to become the U.K. government’s chief scientific adviser. To fill his spot, GSK has recruited Hal Barron, current president of R&D at Calico, the secretive aging biology firm funded by Alphabet, Google’s parent company. Barron was previously chief medical officer at Roche. He will remain in San Francisco to boost GSK’s R&D business development in the city.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment